FCMI
DRNA

Foresite Capital Management IV’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Foresite Capital Management IV’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-25,000
Closed -$635K – 19
2020
Q2 		$635K Buy
+25,000
New +$635K 0.31% 11